nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0248	0.0555	CcSEcCtD
Iloperidone—HTR7—pulmonary artery—dilated cardiomyopathy	0.0197	0.18	CbGeAlD
Iloperidone—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0192	0.175	CbGeAlD
Iloperidone—Breast pain—Spironolactone—dilated cardiomyopathy	0.0157	0.0352	CcSEcCtD
Iloperidone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0156	0.035	CcSEcCtD
Iloperidone—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0123	0.112	CbGeAlD
Iloperidone—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0123	0.0275	CcSEcCtD
Iloperidone—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0119	0.109	CbGeAlD
Iloperidone—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0108	0.0242	CcSEcCtD
Iloperidone—Lethargy—Spironolactone—dilated cardiomyopathy	0.0102	0.0228	CcSEcCtD
Iloperidone—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00929	0.0208	CcSEcCtD
Iloperidone—Gastritis—Spironolactone—dilated cardiomyopathy	0.00882	0.0197	CcSEcCtD
Iloperidone—DRD4—heart—dilated cardiomyopathy	0.00855	0.0782	CbGeAlD
Iloperidone—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00793	0.0178	CcSEcCtD
Iloperidone—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00692	0.0155	CcSEcCtD
Iloperidone—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00676	0.0151	CcSEcCtD
Iloperidone—Breast pain—Lisinopril—dilated cardiomyopathy	0.00642	0.0144	CcSEcCtD
Iloperidone—Gefitinib—EGFR—dilated cardiomyopathy	0.00618	1	CrCbGaD
Iloperidone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00577	0.0129	CcSEcCtD
Iloperidone—Thirst—Furosemide—dilated cardiomyopathy	0.0057	0.0128	CcSEcCtD
Iloperidone—Lethargy—Furosemide—dilated cardiomyopathy	0.00553	0.0124	CcSEcCtD
Iloperidone—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00544	0.0122	CcSEcCtD
Iloperidone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00537	0.012	CcSEcCtD
Iloperidone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00532	0.0119	CcSEcCtD
Iloperidone—Urinary retention—Furosemide—dilated cardiomyopathy	0.00515	0.0115	CcSEcCtD
Iloperidone—Dehydration—Furosemide—dilated cardiomyopathy	0.00504	0.0113	CcSEcCtD
Iloperidone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00495	0.0111	CcSEcCtD
Iloperidone—Confusional state—Spironolactone—dilated cardiomyopathy	0.00494	0.0111	CcSEcCtD
Iloperidone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00493	0.011	CcSEcCtD
Iloperidone—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.00479	0.0439	CbGeAlD
Iloperidone—SIGMAR1—myocardium—dilated cardiomyopathy	0.00451	0.0413	CbGeAlD
Iloperidone—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00446	0.01	CcSEcCtD
Iloperidone—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00441	0.00986	CcSEcCtD
Iloperidone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00439	0.00982	CcSEcCtD
Iloperidone—Somnolence—Spironolactone—dilated cardiomyopathy	0.00435	0.00975	CcSEcCtD
Iloperidone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00433	0.00969	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00423	0.00946	CcSEcCtD
Iloperidone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00404	0.00903	CcSEcCtD
Iloperidone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00403	0.00903	CcSEcCtD
Iloperidone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00395	0.00884	CcSEcCtD
Iloperidone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00387	0.00867	CcSEcCtD
Iloperidone—Dehydration—Lisinopril—dilated cardiomyopathy	0.00378	0.00847	CcSEcCtD
Iloperidone—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00377	0.0344	CbGeAlD
Iloperidone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00371	0.00832	CcSEcCtD
Iloperidone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.0037	0.00829	CcSEcCtD
Iloperidone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00368	0.00823	CcSEcCtD
Iloperidone—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00368	0.00823	CcSEcCtD
Iloperidone—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00364	0.00814	CcSEcCtD
Iloperidone—Gastritis—Lisinopril—dilated cardiomyopathy	0.0036	0.00806	CcSEcCtD
Iloperidone—ADRA2C—myocardium—dilated cardiomyopathy	0.00354	0.0324	CbGeAlD
Iloperidone—Asthma—Lisinopril—dilated cardiomyopathy	0.00352	0.00787	CcSEcCtD
Iloperidone—Eye disorder—Furosemide—dilated cardiomyopathy	0.0035	0.00785	CcSEcCtD
Iloperidone—Tinnitus—Furosemide—dilated cardiomyopathy	0.0035	0.00783	CcSEcCtD
Iloperidone—Angiopathy—Furosemide—dilated cardiomyopathy	0.0034	0.00762	CcSEcCtD
Iloperidone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00335	0.0075	CcSEcCtD
Iloperidone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00335	0.0075	CcSEcCtD
Iloperidone—Dysuria—Lisinopril—dilated cardiomyopathy	0.00329	0.00736	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00327	0.00731	CcSEcCtD
Iloperidone—Malnutrition—Furosemide—dilated cardiomyopathy	0.00326	0.00731	CcSEcCtD
Iloperidone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00324	0.00725	CcSEcCtD
Iloperidone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00324	0.00725	CcSEcCtD
Iloperidone—Weight increased—Lisinopril—dilated cardiomyopathy	0.0032	0.00716	CcSEcCtD
Iloperidone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00318	0.00712	CcSEcCtD
Iloperidone—SIGMAR1—heart—dilated cardiomyopathy	0.00315	0.0288	CbGeAlD
Iloperidone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00314	0.00703	CcSEcCtD
Iloperidone—Rash—Spironolactone—dilated cardiomyopathy	0.00309	0.00691	CcSEcCtD
Iloperidone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00308	0.00691	CcSEcCtD
Iloperidone—Vision blurred—Furosemide—dilated cardiomyopathy	0.00308	0.00689	CcSEcCtD
Iloperidone—Anaemia—Furosemide—dilated cardiomyopathy	0.00302	0.00675	CcSEcCtD
Iloperidone—Agitation—Furosemide—dilated cardiomyopathy	0.003	0.00672	CcSEcCtD
Iloperidone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00296	0.00664	CcSEcCtD
Iloperidone—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00296	0.00662	CcSEcCtD
Iloperidone—Vertigo—Furosemide—dilated cardiomyopathy	0.00293	0.00657	CcSEcCtD
Iloperidone—Leukopenia—Furosemide—dilated cardiomyopathy	0.00292	0.00654	CcSEcCtD
Iloperidone—Nausea—Spironolactone—dilated cardiomyopathy	0.00291	0.00651	CcSEcCtD
Iloperidone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00278	0.00622	CcSEcCtD
Iloperidone—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00276	0.00617	CcSEcCtD
Iloperidone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00272	0.00608	CcSEcCtD
Iloperidone—SIGMAR1—cardiac atrium—dilated cardiomyopathy	0.00269	0.0246	CbGeAlD
Iloperidone—HTR7—heart—dilated cardiomyopathy	0.00269	0.0246	CbGeAlD
Iloperidone—Confusional state—Furosemide—dilated cardiomyopathy	0.00269	0.00601	CcSEcCtD
Iloperidone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00262	0.00587	CcSEcCtD
Iloperidone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00261	0.00585	CcSEcCtD
Iloperidone—ADRA1A—heart—dilated cardiomyopathy	0.00259	0.0237	CbGeAlD
Iloperidone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00255	0.00571	CcSEcCtD
Iloperidone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00254	0.00568	CcSEcCtD
Iloperidone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00251	0.00563	CcSEcCtD
Iloperidone—Hypotension—Furosemide—dilated cardiomyopathy	0.00249	0.00557	CcSEcCtD
Iloperidone—ADRA2C—heart—dilated cardiomyopathy	0.00247	0.0226	CbGeAlD
Iloperidone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00247	0.00552	CcSEcCtD
Iloperidone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00245	0.00548	CcSEcCtD
Iloperidone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00239	0.00536	CcSEcCtD
Iloperidone—Somnolence—Furosemide—dilated cardiomyopathy	0.00237	0.0053	CcSEcCtD
Iloperidone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00235	0.00527	CcSEcCtD
Iloperidone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00231	0.00517	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0023	0.00515	CcSEcCtD
Iloperidone—Fatigue—Furosemide—dilated cardiomyopathy	0.0023	0.00514	CcSEcCtD
Iloperidone—Tremor—Lisinopril—dilated cardiomyopathy	0.00229	0.00514	CcSEcCtD
Iloperidone—Anaemia—Lisinopril—dilated cardiomyopathy	0.00226	0.00507	CcSEcCtD
Iloperidone—Vertigo—Lisinopril—dilated cardiomyopathy	0.0022	0.00493	CcSEcCtD
Iloperidone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0022	0.00492	CcSEcCtD
Iloperidone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00219	0.00491	CcSEcCtD
Iloperidone—Palpitations—Lisinopril—dilated cardiomyopathy	0.00216	0.00485	CcSEcCtD
Iloperidone—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.00211	0.0193	CbGeAlD
Iloperidone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00211	0.00472	CcSEcCtD
Iloperidone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00209	0.00467	CcSEcCtD
Iloperidone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00209	0.00467	CcSEcCtD
Iloperidone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00204	0.00457	CcSEcCtD
Iloperidone—Confusional state—Lisinopril—dilated cardiomyopathy	0.00202	0.00451	CcSEcCtD
Iloperidone—Oedema—Lisinopril—dilated cardiomyopathy	0.002	0.00448	CcSEcCtD
Iloperidone—Infection—Lisinopril—dilated cardiomyopathy	0.00199	0.00445	CcSEcCtD
Iloperidone—ADRA2A—heart—dilated cardiomyopathy	0.00197	0.018	CbGeAlD
Iloperidone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00195	0.00437	CcSEcCtD
Iloperidone—Asthenia—Furosemide—dilated cardiomyopathy	0.00191	0.00428	CcSEcCtD
Iloperidone—Hypotension—Lisinopril—dilated cardiomyopathy	0.00187	0.00418	CcSEcCtD
Iloperidone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00182	0.00408	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00182	0.00408	CcSEcCtD
Iloperidone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00179	0.00402	CcSEcCtD
Iloperidone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00178	0.00399	CcSEcCtD
Iloperidone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00178	0.00398	CcSEcCtD
Iloperidone—Dizziness—Furosemide—dilated cardiomyopathy	0.00176	0.00394	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00173	0.00386	CcSEcCtD
Iloperidone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00172	0.00386	CcSEcCtD
Iloperidone—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00169	0.0154	CbGeAlD
Iloperidone—Rash—Furosemide—dilated cardiomyopathy	0.00168	0.00376	CcSEcCtD
Iloperidone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00168	0.00376	CcSEcCtD
Iloperidone—HTR2A—heart—dilated cardiomyopathy	0.00168	0.0153	CbGeAlD
Iloperidone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00165	0.00369	CcSEcCtD
Iloperidone—Nausea—Furosemide—dilated cardiomyopathy	0.00158	0.00354	CcSEcCtD
Iloperidone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00158	0.00354	CcSEcCtD
Iloperidone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00143	0.00321	CcSEcCtD
Iloperidone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00137	0.00306	CcSEcCtD
Iloperidone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00132	0.00296	CcSEcCtD
Iloperidone—Rash—Lisinopril—dilated cardiomyopathy	0.00126	0.00282	CcSEcCtD
Iloperidone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00126	0.00282	CcSEcCtD
Iloperidone—Nausea—Lisinopril—dilated cardiomyopathy	0.00119	0.00266	CcSEcCtD
Iloperidone—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000123	0.00028	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000121	0.000276	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000121	0.000276	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000121	0.000276	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000121	0.000275	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00012	0.000275	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00012	0.000274	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000118	0.00027	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000118	0.00027	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000117	0.000267	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000116	0.000266	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000116	0.000265	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000115	0.000263	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000115	0.000263	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000115	0.000262	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000115	0.000262	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000115	0.000262	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000114	0.000261	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000114	0.000261	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000113	0.000259	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000113	0.000258	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000113	0.000258	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000112	0.000257	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000112	0.000256	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000112	0.000255	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000111	0.000255	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000111	0.000253	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000111	0.000253	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00011	0.000251	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00011	0.000251	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000108	0.000248	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000108	0.000247	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000108	0.000246	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000107	0.000245	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000107	0.000245	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000107	0.000244	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000107	0.000244	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000107	0.000244	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000106	0.000243	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000106	0.000242	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000106	0.000242	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000105	0.00024	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000105	0.000239	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000105	0.000239	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000104	0.000238	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000104	0.000238	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000104	0.000237	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000104	0.000237	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000103	0.000235	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000102	0.000234	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000102	0.000234	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000101	0.000231	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.99e-05	0.000228	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.97e-05	0.000228	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.96e-05	0.000227	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.94e-05	0.000227	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.84e-05	0.000225	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.8e-05	0.000224	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	9.79e-05	0.000224	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.78e-05	0.000223	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.77e-05	0.000223	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.67e-05	0.000221	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.66e-05	0.000221	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.62e-05	0.00022	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.61e-05	0.000219	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.59e-05	0.000219	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	9.52e-05	0.000217	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.51e-05	0.000217	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.51e-05	0.000217	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.48e-05	0.000216	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.43e-05	0.000215	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.43e-05	0.000215	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.36e-05	0.000214	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.36e-05	0.000214	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	9.35e-05	0.000214	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.34e-05	0.000213	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.28e-05	0.000212	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.28e-05	0.000212	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.26e-05	0.000212	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.26e-05	0.000212	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.23e-05	0.000211	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.22e-05	0.00021	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.17e-05	0.000209	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.16e-05	0.000209	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.11e-05	0.000208	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.1e-05	0.000208	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.09e-05	0.000208	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.09e-05	0.000208	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.09e-05	0.000208	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.04e-05	0.000207	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.03e-05	0.000206	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.99e-05	0.000205	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.91e-05	0.000204	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.9e-05	0.000203	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.88e-05	0.000203	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.82e-05	0.000201	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.77e-05	0.0002	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.71e-05	0.000199	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.7e-05	0.000199	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	8.64e-05	0.000197	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.63e-05	0.000197	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.61e-05	0.000197	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.52e-05	0.000195	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	8.5e-05	0.000194	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.49e-05	0.000194	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	8.48e-05	0.000194	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.45e-05	0.000193	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.44e-05	0.000193	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.44e-05	0.000193	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.36e-05	0.000191	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.34e-05	0.00019	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	8.32e-05	0.00019	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.26e-05	0.000189	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	8.22e-05	0.000188	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.22e-05	0.000188	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	8.21e-05	0.000188	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.18e-05	0.000187	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	8.16e-05	0.000186	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.09e-05	0.000185	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.99e-05	0.000183	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.94e-05	0.000181	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	7.9e-05	0.00018	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	7.86e-05	0.00018	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	7.85e-05	0.000179	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.85e-05	0.000179	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	7.84e-05	0.000179	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.84e-05	0.000179	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.84e-05	0.000179	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.83e-05	0.000179	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.8e-05	0.000178	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	7.79e-05	0.000178	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.73e-05	0.000177	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.73e-05	0.000176	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.72e-05	0.000176	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	7.69e-05	0.000176	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	7.67e-05	0.000175	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.6e-05	0.000174	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.58e-05	0.000173	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.52e-05	0.000172	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	7.51e-05	0.000172	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	7.47e-05	0.000171	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.25e-05	0.000166	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.14e-05	0.000163	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.12e-05	0.000163	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	7.08e-05	0.000162	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.99e-05	0.00016	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	6.98e-05	0.000159	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	6.93e-05	0.000158	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.88e-05	0.000157	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.83e-05	0.000156	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.79e-05	0.000155	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.77e-05	0.000155	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.77e-05	0.000155	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	6.76e-05	0.000154	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.76e-05	0.000154	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.73e-05	0.000154	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	6.73e-05	0.000154	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.7e-05	0.000153	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	6.67e-05	0.000152	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.63e-05	0.000151	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.61e-05	0.000151	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.52e-05	0.000149	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.49e-05	0.000148	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.33e-05	0.000145	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.32e-05	0.000144	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.28e-05	0.000143	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	6.23e-05	0.000142	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.16e-05	0.000141	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.08e-05	0.000139	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	6.07e-05	0.000139	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	6.05e-05	0.000138	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.05e-05	0.000138	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	6e-05	0.000137	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.91e-05	0.000135	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.9e-05	0.000135	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	5.89e-05	0.000134	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.89e-05	0.000134	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.82e-05	0.000133	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	5.81e-05	0.000133	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.81e-05	0.000133	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	5.78e-05	0.000132	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.78e-05	0.000132	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	5.72e-05	0.000131	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.71e-05	0.00013	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.7e-05	0.00013	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	5.62e-05	0.000128	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	5.57e-05	0.000127	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	5.56e-05	0.000127	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	5.46e-05	0.000125	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	5.45e-05	0.000124	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.45e-05	0.000124	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	5.44e-05	0.000124	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	5.41e-05	0.000124	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.37e-05	0.000123	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.37e-05	0.000123	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	5.34e-05	0.000122	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.29e-05	0.000121	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.26e-05	0.00012	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.24e-05	0.00012	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	5.21e-05	0.000119	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.15e-05	0.000118	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	5.1e-05	0.000117	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	5.02e-05	0.000115	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	5.02e-05	0.000115	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	5.01e-05	0.000114	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	5.01e-05	0.000114	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.92e-05	0.000112	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.78e-05	0.000109	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.69e-05	0.000107	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.68e-05	0.000107	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.66e-05	0.000106	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	4.63e-05	0.000106	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	4.57e-05	0.000104	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.53e-05	0.000104	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.11e-05	9.39e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	4.06e-05	9.27e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.05e-05	9.24e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.04e-05	9.22e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.03e-05	9.21e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	4.01e-05	9.17e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.96e-05	9.05e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.95e-05	9.03e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	3.9e-05	8.92e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	3.74e-05	8.54e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	3.73e-05	8.53e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	3.71e-05	8.47e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.68e-05	8.41e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	3.57e-05	8.16e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.56e-05	8.13e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.54e-05	8.09e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.49e-05	7.96e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.48e-05	7.94e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	3.44e-05	7.86e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.41e-05	7.79e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.35e-05	7.65e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.22e-05	7.35e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	3.17e-05	7.25e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.17e-05	7.24e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.02e-05	6.89e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.77e-05	6.32e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	2.75e-05	6.29e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	2.68e-05	6.11e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.65e-05	6.06e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.59e-05	5.91e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.43e-05	5.55e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.39e-05	5.46e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.38e-05	5.45e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.34e-05	5.35e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.33e-05	5.32e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.17e-05	4.97e-05	CbGpPWpGaD
